Study of Emotional Regulation and Underlying Prefrontal Activity in Binge Eating Disorder (EmoBED)

The goal of this exploratory, interventional, multicentre study is to compare the prefrontal activity during a negative emotion regulation task in women with Binge-Eating Disorder (BED) and healthy women with and without Emotional Eating (EE).

The aim of this study is to compare the prefrontal processing of cognitive control of emotions between BED and EE and to compare the emotional processing and emotional experience between BED and EE.

The study will thus compare four experimental groups: patients with BED, BMI-matched healthy volunteers with EE, BMI-matched healthy volunteers, and healthy volunteers of normal weight without BED.

Participants will perform a down-regulation task of negative emotions elicited by negative pictures. During this task, their cerebral activity will be recorded using functional near-infrared spectroscopy (fNIRS), as well as their autonomous activity (skin conductance, pulse rate, respiration rate).

Study Overview

Study Type

Interventional

Enrollment (Estimated)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Women between 18 and 60 years old (including 60)
  • Right-handed.
  • For patients only : diagnosed with Binge Eating Desordors according to DSM criteria.
  • Membership of a French social security scheme or beneficiary of such a scheme.
  • Non-opposition of the subject to participate in the study.

Non inclusion Criteria:

Healthy volunteers only :

  • Suffering from an eating disorder or any other psychiatric disorder.
  • History of bariatric surgery.

All subjects (healthy volunteers and patients) :

  • Rare obesity (genetic or syndromic).
  • Specific addictions (substances or behaviors).
  • Neurological disorders and/or history of stroke or head trauma.
  • Presence of lesions, wounds or dermatitis at the sites where the recording devices are applied.
  • Any serious acute or chronic illness other than the pathology under study, or any treatment likely to interfere with the evaluation of the parameter under study.
  • Inability to follow protocol requirements.
  • Subject unlikely to cooperate with the study and/or poor cooperation anticipated by the investigator.
  • Subject unable to speak French and/or unable to read.
  • Pregnant or breast-feeding women.
  • Persons deprived of their liberty by judicial or administrative decision; persons under compulsory psychiatric care; persons admitted to a health or social institution for purposes other than research.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Patients with binge eating desorders
No drugs were used in this study. All participants perform an emotion regulation task. More precisely, they have to down regulate negative emotions elicited by negative pictures using a cognitive reaprasal strategy. To this end, they have to change the meaning of the picture they are watching in order to decrease motional intensity.
Experimental: healthy volunteers with a low score at the emotion eating scale compare to median
group matched with patients for age and body mass index
No drugs were used in this study. All participants perform an emotion regulation task. More precisely, they have to down regulate negative emotions elicited by negative pictures using a cognitive reaprasal strategy. To this end, they have to change the meaning of the picture they are watching in order to decrease motional intensity.
Experimental: healthy volunteers with a high score at the emotion eating scale compare to median
group matched with patients for age and body mass index
No drugs were used in this study. All participants perform an emotion regulation task. More precisely, they have to down regulate negative emotions elicited by negative pictures using a cognitive reaprasal strategy. To this end, they have to change the meaning of the picture they are watching in order to decrease motional intensity.
Experimental: healthy volunteers normo-weight group with a low score at the emotion eating scale compare to median
healthy volunteers with normo-weight group matched with patients only in age but not in Body Mass Iindex with an Emotional Eating score below the median
No drugs were used in this study. All participants perform an emotion regulation task. More precisely, they have to down regulate negative emotions elicited by negative pictures using a cognitive reaprasal strategy. To this end, they have to change the meaning of the picture they are watching in order to decrease motional intensity.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Measurement of prefrontal cortex activity using functional near-infrared imaging (fNIRS).
Time Frame: Day 1 during the viewing of images with negative valence

The fNIRS signal represents the concentration of oxyhemoglobin and deoxyhemoglobin over time. It provides information about the local oxygen demand of the brain and therefore its activity.

It is these concentrations during the regulatory task that are used as the primary outcome measure.

Day 1 during the viewing of images with negative valence

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Psychophysiological measurements: electrodermal activity
Time Frame: Day 1 during the viewing of images with negative valence
Skin conductance measures are recorded These provide information on the autonomic nervous system (sympathetic and parasympathetic) and thus on emotional processing and arousal.
Day 1 during the viewing of images with negative valence
Psychophysiological measurements: electrocardiogram
Time Frame: Day 1 during the viewing of images with negative valence
Electrocardiogram measures are recorded These provide information on the autonomic nervous system (sympathetic and parasympathetic) and thus on emotional processing and arousal.
Day 1 during the viewing of images with negative valence
Psychophysiological measurements: respiratory rate
Time Frame: Day 1 during the viewing of images with negative valence
Respiratory rate is recorded These provide information on the autonomic nervous system (sympathetic and parasympathetic) and thus on emotional processing and arousal.
Day 1 during the viewing of images with negative valence

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Study Director: AMSALLEM Anne-Cécile, MD, CHU de Besancon

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 24, 2025

Primary Completion (Estimated)

October 30, 2026

Study Completion (Estimated)

October 30, 2026

Study Registration Dates

First Submitted

February 11, 2025

First Submitted That Met QC Criteria

March 3, 2025

First Posted (Actual)

March 7, 2025

Study Record Updates

Last Update Posted (Actual)

July 22, 2025

Last Update Submitted That Met QC Criteria

July 21, 2025

Last Verified

July 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Binge-Eating Disorder

Clinical Trials on Emotion regulation task (fNIRS recording during the emotional regulation task)

Subscribe